Literature DB >> 19097174

Clinical significance of Gata-1, Gata-2, EKLF, and c-MPL expression in acute myeloid leukemia.

Rosa M Ayala1, Joaquín Martínez-López, Enriqueta Albízua, Amalia Diez, Florinda Gilsanz.   

Abstract

The aim of this study was to evaluate the biological correlation and prognostic impact of Gata-1, Gata-2, EKLF, and c-MPL transcript level in a group of 41 acute myeloid leukemia (AML) patients. Gata-1 overexpression was related to advanced age and a low percentage of bone marrow blasts and was associated with the expression of CD34 antigen and lymphoid T markers. The negative impact of Gata-1 expression on the probability of achieving complete remission has been confirmed. Gata-2 overexpression was associated with a low percentage of blasts in BM and males. Expression of c-MPL was associated with CD34+ AML and M2 FAB AML subtype. A higher expression of EKLF was found in secondary AML versus primary AML. Nevertheless, patients expressing EKLF had a longer overall survival and event free survival than those patients that did not express EKLF. Our study has identified expression of EKLF as a factor with a favorable impact on prognosis in AML.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19097174     DOI: 10.1002/ajh.21332

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  13 in total

1.  Histone methyltransferase Setd8 represses Gata2 expression and regulates erythroid maturation.

Authors:  Jeffrey Malik; Michael Getman; Laurie A Steiner
Journal:  Mol Cell Biol       Date:  2015-04-06       Impact factor: 4.272

2.  Increased CD34+CD38 -CD123 + cells in myelodysplastic syndrome displaying malignant features similar to those in AML.

Authors:  Li Juan Li; Jing Lian Tao; Rong Fu; Hua Quan Wang; Hui Juan Jiang; Lan Zhu Yue; Wei Zhang; Hui Liu; Zong Hong Shao
Journal:  Int J Hematol       Date:  2014-05-21       Impact factor: 2.490

Review 3.  Master regulatory GATA transcription factors: mechanistic principles and emerging links to hematologic malignancies.

Authors:  Emery H Bresnick; Koichi R Katsumura; Hsiang-Ying Lee; Kirby D Johnson; Archibald S Perkins
Journal:  Nucleic Acids Res       Date:  2012-04-05       Impact factor: 16.971

4.  Acute myeloid leukemia and transcription factors: role of erythroid Krüppel-like factor (EKLF).

Authors:  Rosa Ayala; Joaquin Martínez-López; Florinda Gilsanz
Journal:  Cancer Cell Int       Date:  2012-06-07       Impact factor: 5.722

5.  Genome-wide analysis of transcriptional reprogramming in mouse models of acute myeloid leukaemia.

Authors:  Nicolas Bonadies; Samuel D Foster; Wai-In Chan; Brynn T Kvinlaug; Dominik Spensberger; Mark A Dawson; Elaine Spooncer; Anthony D Whetton; Andrew J Bannister; Brian J Huntly; Berthold Göttgens
Journal:  PLoS One       Date:  2011-01-28       Impact factor: 3.240

Review 6.  Spectrum of myeloid neoplasms and immune deficiency associated with germline GATA2 mutations.

Authors:  Muhammad A Mir; Samith T Kochuparambil; Roshini S Abraham; Vilmarie Rodriguez; Matthew Howard; Amy P Hsu; Amie E Jackson; Steven M Holland; Mrinal M Patnaik
Journal:  Cancer Med       Date:  2015-01-26       Impact factor: 4.452

7.  Overexpression of GATA1 confers resistance to chemotherapy in acute megakaryocytic Leukemia.

Authors:  John Timothy Caldwell; Holly Edwards; Alan A Dombkowski; Steven A Buck; Larry H Matherly; Yubin Ge; Jeffrey W Taub
Journal:  PLoS One       Date:  2013-07-10       Impact factor: 3.240

8.  Inhibition of poly(ADP-ribose) polymerase 1 protects against acute myeloid leukemia by suppressing the myeloproliferative leukemia virus oncogene.

Authors:  Lingbo Wang; Weili Cai; Wei Zhang; Xueying Chen; Wenqian Dong; Dongqi Tang; Yun Zhang; Chunyan Ji; Mingxiang Zhang
Journal:  Oncotarget       Date:  2015-09-29

9.  GATA factors in human neuroblastoma: distinctive expression patterns in clinical subtypes.

Authors:  V Hoene; M Fischer; A Ivanova; T Wallach; F Berthold; C Dame
Journal:  Br J Cancer       Date:  2009-08-25       Impact factor: 7.640

10.  Pure erythroid leukemia in advanced breast cancer.

Authors:  Pasquale Niscola; Andrea Tendas; Mauro Minelli; Alessio Perrotti; Paolo de Fabritiis; Giovanni Del Poeta
Journal:  Blood Res       Date:  2014-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.